Severe malaria and artesunate treatment, Norway.
Mørch
Kristine
K
Strand
Øystein
Ø
Dunlop
Oona
O
Berg
Ase
A
Langeland
Nina
N
Leiva
Rafael A M
RA
Longva
Jørn-Age
JA
Sjursen
Håkon
H
Skrede
Steinar
S
Sundal
Jon
J
Jensenius
Mogens
M
D000284:Administration, Oral; D000328:Adult; D000962:Antimalarials / Q000008:administration & dosage / Q000627:therapeutic use*; D037621:Artemisinins / Q000008:administration & dosage / Q000627:therapeutic use*; D000077332:Artesunate; D002981:Clindamycin / Q000008:administration & dosage / Q000627:therapeutic use; D004318:Doxycycline / Q000008:administration & dosage / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D007275:Injections, Intravenous; D016778:Malaria, Falciparum / Q000188:drug therapy*; D008499:Medical Records; D008875:Middle Aged; D009664:Norway; D011500:Protein Synthesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D012189:Retrospective Studies; D016896:Treatment Outcome
D000962:Antimalarials; D037621:Artemisinins; D011500:Protein Synthesis Inhibitors; D002981:Clindamycin; D000077332:Artesunate; D004318:Doxycycline